We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$775M
AUM Growth
-$436M
Cap. Flow
-$471M
Cap. Flow %
-60.72%
Top 10 Hldgs %
18.21%
Holding
4,545
New
711
Increased
1,179
Reduced
1,568
Closed
1,030

Sector Composition

Rank Sector Weight
1 Financials 11.08%
2 Technology 10%
3 Consumer Discretionary 7.02%
4 Healthcare 6.86%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPG
2851
DELISTED
Washington Prime Group Inc.
WPG
$6K ﹤0.01%
98
-3,249
-97% -$221K
CMO
2852
DELISTED
Capstead Mortgage Corp.
CMO
$6K ﹤0.01%
700
-3,637
-84% -$33.4K
SORL
2853
DELISTED
SORL Auto Parts, Inc.
SORL
$6K ﹤0.01%
+948
New +$5.69K
ACRE
2854
Ares Commercial Real Estate
ACRE
$261M
$5K ﹤0.01%
+363
New +$4.83K
ACU icon
2855
Acme United Corp
ACU
$211M
$5K ﹤0.01%
200
+196
+4,900% +$4.57K
ALOT icon
2856
AstroNova
ALOT
$226M
$5K ﹤0.01%
352
-1,082
-75% -$14.3K
AMH icon
2857
American Homes 4 Rent
AMH
$12.4B
$5K ﹤0.01%
245
-3,252
-93% -$70.6K
ARKR icon
2858
Ark Restaurants
ARKR
$20.2M
$5K ﹤0.01%
+201
New +$4.98K
BRZU icon
2859
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$102M
$5K ﹤0.01%
4
+3
+300% +$4.31K
CAAS icon
2860
China Automotive Systems
CAAS
$131M
$5K ﹤0.01%
1,131
+87
+8% +$440
CDTX
2861
DELISTED
Cidara Therapeutics
CDTX
$5K ﹤0.01%
34
+22
+183% +$3.34K
CDZI icon
2862
Cadiz
CDZI
$273M
$5K ﹤0.01%
322
-1,030
-76% -$13.6K
CEE
2863
Central and Eastern Europe Fund
CEE
$137M
$5K ﹤0.01%
200
+52
+35% +$1.28K
CHD icon
2864
Church & Dwight Co
CHD
$24.6B
$5K ﹤0.01%
90
-326
-78% -$15.3K
CLMB icon
2865
Climb Global Solutions
CLMB
$506M
$5K ﹤0.01%
1,200
+332
+38% +$1.24K
CLS icon
2866
Celestica
CLS
$41.7B
$5K ﹤0.01%
483
-2,877
-86% -$31.8K
CMC icon
2867
Commercial Metals
CMC
$8.37B
$5K ﹤0.01%
230
-13,730
-98% -$273K
CODX
2868
Co-Diagnostics
CODX
$5.56M
$5K ﹤0.01%
66
+55
+500% +$8.23K
CPIX icon
2869
Cumberland Pharmaceuticals
CPIX
$113M
$5K ﹤0.01%
721
+287
+66% +$2.11K
CRUS icon
2870
Cirrus Logic
CRUS
$6.53B
$5K ﹤0.01%
99
-5,423
-98% -$293K
CSIQ icon
2871
Canadian Solar
CSIQ
$1.05B
$5K ﹤0.01%
313
-312
-50% -$5.36K
CTSO icon
2872
Cytosorbents Corp
CTSO
$23.7M
$5K ﹤0.01%
+778
New +$4.95K
DBRG icon
2873
DigitalBridge
DBRG
$2.94B
$5K ﹤0.01%
100
-1,172
-92% -$57.6K
DMRC icon
2874
Digimarc Corp
DMRC
$167M
$5K ﹤0.01%
140
-642
-82% -$23.3K
EDU icon
2875
New Oriental
EDU
$9.06B
$5K ﹤0.01%
55
-7,129
-99% -$633K

Similar funds

Tower Research Capital (TRC)'s Q4 2017 Portfolio in Review

As of Q4 2017, Tower Research Capital (TRC) held 4,545 positions worth $775M, down 36% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Tower Research Capital (TRC) withdrew a net $471M in Q4 2017, closing 1,030 positions and reducing 1,568 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 6.3% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Berkshire Hathaway Class B worth $7.94M.

  • Tower Research Capital (TRC)'s largest Q4 2017 buy was Berkshire Hathaway Class B: 40,072 shares worth $7.94M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2017, an estimated $8.74M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $223M.
  • Tower Research Capital (TRC) fully exited iShares MSCI EAFE ETF in Q4 2017, selling an estimated $25.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 18% of its $775M portfolio in Q4 2017.
  • Tower Research Capital (TRC) opened 711 new positions and closed 1,030 in Q4 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $775M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.